Financhill
Buy
51

HCI Quote, Financials, Valuation and Earnings

Last price:
$113.73
Seasonality move :
9.05%
Day range:
$107.06 - $115.17
52-week range:
$81.35 - $126.50
Dividend yield:
1.41%
P/E ratio:
9.47x
P/S ratio:
1.79x
P/B ratio:
2.62x
Volume:
184.8K
Avg. volume:
145.2K
1-year change:
33.28%
Market cap:
$1.2B
Revenue:
$550M
EPS (TTM):
$11.97
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $241.4M $275.7M $402.6M $492M $550M
Revenue Growth (YoY) 4.36% 14.23% 45.99% 22.22% 11.79%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $31.1M $33.8M $45.4M $56.5M $53.9M
Other Inc / (Exp) $1.9M $1.9M $6.4M $4.5M $2.6M
Operating Expenses $43.3M $85M $67.3M $82.3M $76.5M
Operating Income -- -- -- -- --
 
Net Interest Expenses $13.1M $11.7M $8.2M $7.8M $11.1M
EBT. Incl. Unusual Items $36.1M $36.9M $11.2M -$68.4M $117.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $9.5M $9.3M $4M -$13.8M $28.4M
Net Income to Company $26.6M $27.6M $7.2M -$54.6M $89.3M
 
Minority Interest in Earnings -- -- -$5.4M -$3.9M -$10.2M
Net Income to Common Excl Extra Items $26.6M $27.6M $1.9M -$58.5M $79M
 
Basic EPS (Cont. Ops) $3.32 $3.55 $0.23 -$6.24 $9.13
Diluted EPS (Cont. Ops) $3.31 $3.49 $0.21 -$6.24 $7.62
Weighted Average Basic Share $7.6M $7.4M $8.1M $8.8M $8.4M
Weighted Average Diluted Share $10.2M $9.7M $8.6M $8.8M $11M
 
EBITDA -- -- -- -- --
EBIT $49M $48.5M $17.5M -$60.8M $128.7M
 
Revenue (Reported) $241.4M $275.7M $402.6M $492M $550M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $49M $48.5M $17.5M -$60.8M $128.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $66.5M $97.6M $125.4M $131.5M $175.2M
Revenue Growth (YoY) 10.8% 46.88% 28.46% 4.9% 33.22%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $9.9M $11.5M $15.8M $13.9M $19.2M
Other Inc / (Exp) $421K $2.1M $1.3M $260K $1M
Operating Expenses $50.5M $16.8M $23M $19.2M $26M
Operating Income -- -- -- -- --
 
Net Interest Expenses $2.9M $2.9M $2.8M $2.8M $3.4M
EBT. Incl. Unusual Items $21.5M -$6.5M -$63.6M $20.1M $14.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $6.1M -$1.6M -$12.1M $4.4M $4.7M
Net Income to Company $15.4M -$4.9M -$51.5M $15.7M $9.4M
 
Minority Interest in Earnings -- -$1.4M $544K -$2.5M -$3.7M
Net Income to Common Excl Extra Items $15.4M -$6.3M -$51M $13.2M $5.7M
 
Basic EPS (Cont. Ops) $1.97 -$0.72 -$5.66 $1.53 $0.54
Diluted EPS (Cont. Ops) $1.70 -$0.72 -$5.66 $1.34 $0.52
Weighted Average Basic Share $7.4M $8M $8.4M $8.3M $10.1M
Weighted Average Diluted Share $9.7M $8M $8.4M $11M $10.5M
 
EBITDA -- -- -- -- --
EBIT $24.4M -$4.8M -$60.8M $22.9M $17.5M
 
Revenue (Reported) $66.5M $97.6M $125.4M $131.5M $175.2M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $24.4M -$4.8M -$60.8M $22.9M $17.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $268M $361.6M $486.9M $503.3M $750.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $35.8M $37.6M $58.9M $53M $65.2M
Other Inc / (Exp) $2.1M $3.8M $6M $3.8M $2.3M
Operating Expenses $86.5M $55.3M $86.9M $74.8M $92.5M
Operating Income -- -- -- -- --
 
Net Interest Expenses $11.8M $9.9M $6.1M $11.1M $12.8M
EBT. Incl. Unusual Items $42.8M $11.6M -$68.6M $66.2M $221.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $11.5M $3.1M -$12.8M $15.2M $57.3M
Net Income to Company $31.3M $8.5M -$55.8M $51M $164.4M
 
Minority Interest in Earnings -- -$4M -$4.2M -$8.5M -$18.9M
Net Income to Common Excl Extra Items $31.3M $4.5M -$60M $42.5M $145.5M
 
Basic EPS (Cont. Ops) $4.04 $0.70 -$6.60 $4.94 $14.79
Diluted EPS (Cont. Ops) $3.67 $0.62 -$6.60 $4.34 $11.97
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT $54.4M $20.1M -$63.1M $77.2M $234.5M
 
Revenue (Reported) $268M $361.6M $486.9M $503.3M $750.7M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $54.4M $20.1M -$63.1M $77.2M $234.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $205.9M $291.7M $376.1M $387.4M $588M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $28M $31.7M $45.2M $41.6M $52.9M
Other Inc / (Exp) $1.6M $3.5M $3.1M $2.4M $2.1M
Operating Expenses $75.6M $46M $65.6M $58.9M $74.9M
Operating Income -- -- -- -- --
 
Net Interest Expenses $8.8M $7M $4.9M $8.3M $10M
EBT. Incl. Unusual Items $34M $8.7M -$71.2M $63.5M $167.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $9.1M $2.9M -$13.9M $15.1M $44.1M
Net Income to Company $24.9M $5.8M -$57.3M $48.3M $123.4M
 
Minority Interest in Earnings -- -$4M -$2.8M -$7.4M -$16.1M
Net Income to Common Excl Extra Items $24.9M $1.8M -$60M $40.9M $107.4M
 
Basic EPS (Cont. Ops) $3.20 $0.35 -$6.61 $4.76 $10.48
Diluted EPS (Cont. Ops) $2.85 $0.27 -$6.61 $4.16 $8.57
Weighted Average Basic Share $22M $23M $26.9M $24.9M $29.8M
Weighted Average Diluted Share $26.7M $25.9M $27.2M $32.8M $35.8M
 
EBITDA -- -- -- -- --
EBIT $42.9M $14.4M -$66.2M $71.8M $177.6M
 
Revenue (Reported) $205.9M $291.7M $376.1M $387.4M $588M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $42.9M $14.4M -$66.2M $71.8M $177.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $229.2M $431.3M $628.9M $234.9M $536.5M
Short Term Investments $203.3M $71.7M $42.6M $265.4M $234M
Accounts Receivable, Net $162.4M $164.4M $147.9M $739.7M $452.6M
Inventory -- -- -- -- --
Prepaid Expenses $20.1M $38.7M $29.2M $69.5M $89.1M
Other Current Assets -- -- -- -- --
Total Current Assets $617.7M $711.4M $856.6M $1.3B $1.4B
 
Property Plant And Equipment $15.2M $16.8M $16.4M $19.5M $31.5M
Long-Term Investments $267.7M $151.2M $122.8M $544.2M $452.4M
Goodwill -- -- -- -- --
Other Intangibles $4.2M $3.6M $10.6M $10.6M $7.7M
Other Long-Term Assets -- -- -- -- --
Total Assets $802.6M $941.3M $1.2B $1.8B $1.8B
 
Accounts Payable $76K $87K $23.3M $26.3M $12.9M
Accrued Expenses $10.1M $10.2M $15.5M $14.5M $19.7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $513K $4M $2.2M $734K $1.4M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $20.4M $47.8M $56M $41.5M $41.8M
 
Long-Term Debt $163.6M $156.5M $45.5M $211.7M $208.5M
Capital Leases -- -- -- -- --
Total Liabilities $617.1M $740.2M $762.4M $1.5B $1.4B
 
Common Stock -- -- -- -- --
Other Common Equity Adj $2.2M $1.5M $498K -$9.9M -$3.2M
Common Equity $185.5M $201.1M $323.4M $162.6M $324.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $91.1M $92.2M $98.5M
Total Equity $185.5M $201.1M $414.5M $254.8M $423.3M
 
Total Liabilities and Equity $802.6M $941.3M $1.2B $1.8B $1.8B
Cash and Short Terms $432.5M $503.1M $671.5M $500.2M $770.5M
Total Debt $173.4M $180.2M $60.5M $211.7M $208.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $410.7M $569.1M $355.7M $324M $518.8M
Short Term Investments $92.7M $46.1M $360.6M $418.7M $439M
Accounts Receivable, Net $129.9M $94M $1B $571.4M $410.3M
Inventory -- -- -- -- --
Prepaid Expenses $44.9M $51.5M $107.9M $100.6M $109.8M
Other Current Assets -- -- -- -- --
Total Current Assets $681.9M $761.1M $1.9B $1.5B $1.5B
 
Property Plant And Equipment $18.4M $16.5M $19.3M $30.2M $31.5M
Long-Term Investments $163.7M $122.7M $420M $481.8M $746.1M
Goodwill -- -- -- -- --
Other Intangibles -- $10.8M $13.7M $8.3M $5.8M
Other Long-Term Assets -- -- -- -- --
Total Assets $887.8M $1.1B $2.1B $1.7B $2B
 
Accounts Payable $92K $4.8M $3M $7M $7.5M
Accrued Expenses $15.9M $15.2M $18.8M $25.9M $37.1M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- $2.6M $1.5M $1.5M $1.3M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $24.7M $26.2M $23.4M $34.4M $91.9M
 
Long-Term Debt $155.6M $78M $211.7M $208.3M $185.1M
Capital Leases -- -- -- -- --
Total Liabilities $688.1M $695.9M $1.9B $1.4B $1.5B
 
Common Stock -- -- -- -- --
Other Common Equity Adj $1.6M $799K -$10.8M -$6M $1.9M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $88.7M $90.2M $94.9M $12.8M
Total Equity $199.7M $380.3M $264.4M $294.9M $468.2M
 
Total Liabilities and Equity $887.8M $1.1B $2.1B $1.7B $2B
Cash and Short Terms $503.4M $615.2M $716.3M $742.7M $957.8M
Total Debt $164.4M $78M $211.7M $208.3M $231.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $26.6M $27.6M $7.2M -$54.6M $89.3M
Depreciation & Amoritzation $8.9M $8.7M $5.5M $8M $8.2M
Stock-Based Compensation $6.5M $8.1M $13.8M $15.1M $9.3M
Change in Accounts Receivable -$12.2M $348K $9M -$580.5M $313.9M
Change in Inventories -- -- -- -- --
Cash From Operations $54M $77.3M $96.5M -$12K $230.7M
 
Capital Expenditures $2.9M $6.4M $3.3M $10.1M $8.3M
Cash Acquisitions -$1.2M -$4.2M -$3.8M -$2M -$1.5M
Cash From Investing $50.5M $143.2M $36.9M -$434.5M $4.3M
 
Dividends Paid (Ex Special Dividend) -$13M -$12.7M -$14.1M -$15.2M -$13.7M
Special Dividend Paid
Long-Term Debt Issued -- $10M -- $172.5M $12M
Long-Term Debt Repaid -$91.3M -$21.5M -$9.7M -$16M -$7.5M
Repurchase of Common Stock -$20.1M -$6.7M -$1.3M -$88.3M -$784K
Other Financing Activities -$153K $141K $89.4M -$11.9M -$7.5M
Cash From Financing -$114.7M -$16.7M $64.3M $41.1M $67.1M
 
Beginning Cash (CF) $240.2M $229.9M $433.7M $631.3M $237.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$10.2M $203.8M $197.7M -$393.5M $302M
Ending Cash (CF) $229.9M $433.7M $631.3M $237.8M $539.8M
 
Levered Free Cash Flow $51.2M $70.9M $93.2M -$10.2M $222.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $15.4M -$4.9M -$51.5M $15.7M $9.4M
Depreciation & Amoritzation $2.1M $1.3M $2.2M $2M $2.2M
Stock-Based Compensation $2.2M $2.7M $4.1M $1.8M $3.5M
Change in Accounts Receivable $4.6M $38.8M -$900M $55.3M $9.8M
Change in Inventories -- -- -- -- --
Cash From Operations -$32.5M -$47M -$39.9M $71.4M $104.1M
 
Capital Expenditures $579K $1.3M $1.2M $4.2M $952K
Cash Acquisitions -$1.5M -$137K -$213K -$868K -$98K
Cash From Investing $47.8M -$2.7M $48.7M -$34M -$25.6M
 
Dividends Paid (Ex Special Dividend) -$3.2M -$3.3M -$3.6M -$3.4M -$4.2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- -$2M
Long-Term Debt Repaid -$7.3M -$244K -$253K -$109K -$131K
Repurchase of Common Stock -$32K -- -$6.2M -- --
Other Financing Activities $76K -$3.9M -$3.3M -$3.8M $793K
Cash From Financing -$25.5M -$7.5M -$13.3M -$7.4M -$5.5M
 
Beginning Cash (CF) $423.2M $628.7M $363.1M $297M $449.1M
Foreign Exchange Rate Adjustment $45K $3K -$30K -$38K -$24K
Additions / Reductions -$10.1M -$57.2M -$4.5M $30.1M $73M
Ending Cash (CF) $413.1M $571.5M $358.6M $327M $522.1M
 
Levered Free Cash Flow -$33M -$48.3M -$41.1M $67.2M $103.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $31.3M $8.5M -$55.8M $51M $164.4M
Depreciation & Amoritzation $8.8M $6.5M $6.9M $8.6M $4.1M
Stock-Based Compensation $7.8M $11.3M $17.2M $8.2M $11M
Change in Accounts Receivable $66.5M $32M -$914.5M $468.9M $172.1M
Change in Inventories -- -- -- -- --
Cash From Operations $93.5M $48.5M $29.6M $95.6M $410.5M
 
Capital Expenditures $6.6M $3.1M $10M $7.9M $4.3M
Cash Acquisitions -$2.2M -$2.1M -$4.3M -$1.4M -$1.9M
Cash From Investing $139.7M $44.5M -$309.6M -$97.5M -$226.5M
 
Dividends Paid (Ex Special Dividend) -$12.7M -$13.1M -$15.9M -$13.8M -$15.8M
Special Dividend Paid
Long-Term Debt Issued $10M -- -- -- --
Long-Term Debt Repaid -$21.6M -$24.7M -$1M -$7.6M -$978K
Repurchase of Common Stock -$10.3M -$1.5M -$76.2M -$12.9M -$1M
Other Financing Activities $140K $89.9M -$12.3M -$7.4M -$101.6M
Cash From Financing -$35.4M $65.5M $67.2M -$29.6M $11.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $197.8M $158.5M -$212.8M -$31.5M $195.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $86.8M $45.4M $19.6M $87.7M $406.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $24.9M $5.8M -$57.3M $48.3M $123.4M
Depreciation & Amoritzation $6.5M $4.3M $5.7M $6.2M $2.1M
Stock-Based Compensation $6M $9.2M $12.7M $5.8M $7.4M
Change in Accounts Receivable $29.9M $61.5M -$862M $187.5M $45.7M
Change in Inventories -- -- -- -- --
Cash From Operations $77.5M $48.7M -$18.3M $77.3M $257.1M
 
Capital Expenditures $5.9M $2.6M $9.2M $7M $3M
Cash Acquisitions -$3M -$837K -$1.4M -$756K -$1.2M
Cash From Investing $133.8M $35.1M -$311.4M $25.7M -$205.1M
 
Dividends Paid (Ex Special Dividend) -$9.5M -$9.9M -$11.8M -$10.3M -$12.4M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $10M -- $172.5M $12M $46M
Long-Term Debt Repaid -$21.3M -$24.5M -$15.8M -$7.3M -$853K
Repurchase of Common Stock -$6.5M -$1.3M -$76.2M -$784K -$1M
Other Financing Activities $64K $89.8M -$11.9M -$7.3M -$101.5M
Cash From Financing -$28.2M $54.1M $57M -$13.8M -$69.7M
 
Beginning Cash (CF) $970.9M $1.6B $1.6B $839.8M $1.6B
Foreign Exchange Rate Adjustment -$6K -$42K -$86K -$40K -$35K
Additions / Reductions $183.2M $137.8M -$272.7M $89.3M -$17.6M
Ending Cash (CF) $1.2B $1.8B $1.3B $929M $1.6B
 
Levered Free Cash Flow $71.6M $46.1M -$27.5M $70.4M $254.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock